Published in Int J Cell Biol on October 10, 2013
Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons. Acta Neuropathol (2016) 0.80
Epigenetics and inheritance of phenotype variation in livestock. Epigenetics Chromatin (2016) 0.76
Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus (2016) 0.75
Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates. Sci Rep (2017) 0.75
Types and Strains: Their Essential Role in Understanding Protein Aggregation in Neurodegenerative Diseases. Front Aging Neurosci (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci (2003) 8.44
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Synthetic mammalian prions. Science (2004) 7.35
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med (2008) 6.86
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J (1996) 6.66
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (2012) 6.66
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
NMR structure of the mouse prion protein domain PrP(121-231). Nature (1996) 6.37
Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26
Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (2001) 6.20
Self-replication and scrapie. Nature (1967) 6.01
The most infectious prion protein particles. Nature (2005) 5.37
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet (2004) 4.59
Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science (1990) 4.19
Does the agent of scrapie replicate without nucleic acid? Nature (1967) 4.14
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med (2012) 3.98
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol (2009) 3.55
Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol (2010) 3.19
Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet (2006) 3.12
Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron (2007) 2.58
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet (2002) 2.44
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci (2000) 2.41
Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron (1998) 2.40
Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev (1996) 2.39
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36
Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol (2007) 2.31
Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14
De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A (2008) 2.10
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A (2012) 1.97
High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry (1996) 1.87
Folding of prion protein to its native alpha-helical conformation is under kinetic control. J Biol Chem (2001) 1.84
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A (2012) 1.77
The possible nature of the transmissible agent of scrapie. Vet Rec (1967) 1.68
In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog (2007) 1.56
Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog (2011) 1.53
Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron (2009) 1.49
Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry (1997) 1.48
Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci U S A (1981) 1.33
De novo induction of amyloid-β deposition in vivo. Mol Psychiatry (2011) 1.32
Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol (1994) 1.31
Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci (2009) 1.27
A new mechanism for transmissible prion diseases. J Neurosci (2012) 1.25
Exosomes: a bubble ride for prions? Traffic (2005) 1.24
The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol (1995) 1.19
Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proc Natl Acad Sci U S A (2004) 1.18
Scrapie agent: prions or virinos? Nature (1982) 1.13
Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog (2011) 1.06
Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A (2012) 1.03
Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol (2009) 1.02
Rodent models for prion diseases. Vet Res (2008) 1.01
Slow, latent and temperate virus infections of the central nervous system. Res Publ Assoc Res Nerv Ment Dis (1968) 0.92
Variably protease-sensitive prionopathy: a novel disease of the prion protein. J Mol Neurosci (2011) 0.87
Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids (2002) 0.86
Prion diseases: pathogenesis and public health concerns. FEBS Lett (2002) 0.83
UK patient first to contract vCJD via blood transfusion. CMAJ (2004) 0.76
Effective gene therapy in a mouse model of prion diseases. PLoS One (2008) 0.92
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. J Cell Sci (2004) 0.91
Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J Gen Virol (2004) 0.88
Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity. J Neurosci (2011) 0.88
Increased amyloid-β peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice. Neuropsychopharmacology (2012) 0.80
Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions. Curr Top Med Chem (2013) 0.78
Homologous yeast lipases/acyltransferases exhibit remarkable cold-active properties. Appl Microbiol Biotechnol (2014) 0.75
[Cell culture models of transmissible spongiform encephalopathies]. C R Biol (2002) 0.75